This week's Fierce Biotech is brought to you by Charles River.

Complimentary Whitepaper Download

Hi E, check out this Fierce Whitepaper we think you'll like:

Antibodies: The Breakthrough Past, Blockbuster Present and Cutting-Edge Future

In this white paper, we look at the past, present and future of antibodies as therapies, explaining how the modality became a key pillar of the biopharma industry—and looking forward to the methods and technologies that could unleash its full potential in the years to come.

The paper covers:

• How and why antibodies became a major modality
• The therapeutic areas where antibody-based therapies are used
• How antibodies form the basis of a range of novel modalities
• The remaining challenges facing the field, and potential solutions
• The paper is essential reading for biopharma companies that want to build biologic pipelines and anyone interested in how antibodies transformed the industry.